According to the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), a person’s A1C results may be as follows: The following chart gives a rough idea of how a child’s ...

An alpha-glucosidase inhibitor will usually lower your A1c (the "average" of your blood sugar control over a few months) by about 0.5% to 0.8%. If you're also taking other diabetes medications or ...

interactive diabetes self-management education programs such as the Conversation Map tools may be an effective model for the reduction of patient A1c levels.

A daily pill from drugmaker Eli Lilly has shown safety results comparable to the leading injectable GLP-1 drugs Mounjaro and Ozempic, the company announced Thursday. The once-daily pill, called ...

A daily pill from Eli Lilly lowered blood sugar levels and induced weight loss in people with Type 2 diabetes, the company announced Thursday.